secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2024-06-24T23:59:59+00:00
Accession:  0001628280-24-029643
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ChromaDex shareholders elect all 8 director nominees, ratify auditor, and approve say-on-pay at 2024 annual meeting
--------------------------------------------------------------------------------

- All eight director nominees elected: Jaksch, Fried, Rubin, Yu, Ng, Patrick, Cohen, Shahbazi.
- Ratification of Marcum LLP as FY 2024 auditor passed with 49.6M for, 3.4M against, 83,650 abstain.
- Advisory approval of named executive officer compensation passed with 40.8M for, 0.9M against, 0.5M abstain.
- Broker non-votes of 10.9M reported for director election and say-on-pay proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000162828024029643/0001628280-24-029643-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000162828024029643/cdxc-20240620.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-029643

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer